ClinicalMetric / Countries / Czech Republic / atypical hemolytic uremic syndrome
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

atypical hemolytic uremic syndrome Clinical Trials in Czech Republic

Active clinical trials for atypical hemolytic uremic syndrome with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT05795140 Phase 3
Recruiting

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Enrollment
125 pts
Country
🇨🇿 Czech Republic
Novartis Pharmaceuticals
View Trial →

Frequently Asked Questions

How many atypical hemolytic uremic syndrome clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for atypical hemolytic uremic syndrome with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a atypical hemolytic uremic syndrome clinical trial in Czech Republic?
To join a atypical hemolytic uremic syndrome clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atypical hemolytic uremic syndrome trials in Czech Republic?
Active atypical hemolytic uremic syndrome trials in Czech Republic span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global atypical hemolytic uremic syndrome Trials → All Countries → All Trials →